Nutech’s Affinity

NuTech Takes a Fresh Approach to Allografts with Affinity

Reality testing: A respected, cutting-edge biomedical company needed to elevate their approach to introducing their newest regenerative breakthrough to the healthcare marketplace in a way that powerfully illustrates the benefits of Affinity, the first fresh amniotic allograft. Previously, surgeons could choose only between dehydrated or cryo-preserved allografts, techniques which both impact the bioactivity of healing.

Envisioning a new reality: NuTech chose REALITYRx as their strategic partner to position and distinguish Affinity as the first-of-its-kind product, emphasizing the proprietary process that is utilized to uniquely retain its bioactive healing qualities.

Inventing the reality: The outcome of the agency’s efforts resulted in an illustrious and memorable campaign, in which REALITYRx is helping to catapult Affinity to the forefront of surgeon’s minds, promoting its more active, biocompatible usage and longest viability than ever before possible.

NuTech is in the process of promoting their new campaign to surgeons with a focus on orthopedic medicine. However, the potential for greater utility of their product is tremendous and will continue to evolve in the healthcare community. The creative campaign successfully shifts the surgeon’s mindset to the benefits of “fresh allograft”; it plays a pivotal role in the uptake of Affinity with striking print advertisements and a comprehensive product brochure detailing all the benefits offered to surgeons and their patients. Look for more news from REALITYRx and NuTech soon as they continue to expand their impact with compelling advantages in medicine.


Launch Brochure

Comprehensive selling aid that clearly and creatively establishes the healing benefits of Affinity

Web Ad

Part of a full launch campaign, branded web ads helped efficiently announce the new product to the marketplace

Affinity Product Shot

Provides a differentiating look at fresh allograft versus dry or cryopreserved options.




NuTech Takes a Fresh Approach to Allografts with Affinity

Reality testing: A respected, cutting-edge biomedical company needed to elevate their approach to introducing their newest regenerative breakthrough to the healthcare marketplace in a way that powerfully illustrates the benefits of Affinity, the first fresh amniotic allograft. Previously, surgeons could choose only between dehydrated or cryo-preserved allografts, techniques which both impact the bioactivity of healing. Envisioning a new reality: NuTech chose REALITYRx as their strategic partner to position and distinguish Affinity as the first-of-its-kind product, emphasizing the proprietary process that is utilized to uniquely retain its bioactive healing qualities. Inventing the reality: The outcome of the agency’s efforts resulted in an illustrious and memorable campaign, in which REALITYRx is helping to catapult Affinity to the forefront of surgeon’s minds, promoting its more active, biocompatible usage and longest viability than ever before possible. NuTech is in the process of promoting their new campaign to surgeons with a focus on orthopedic medicine. However, the potential for greater utility of their product is tremendous and will continue to evolve in the healthcare community. The creative campaign successfully shifts the surgeon’s mindset to the benefits of “fresh allograft”; it plays a pivotal role in the uptake of Affinity with striking print advertisements and a comprehensive product brochure detailing all the benefits offered to surgeons and their patients. Look for more news from REALITYRx and NuTech soon as they continue to expand their impact with compelling advantages in medicine.


Launch Brochure

Comprehensive selling aid that clearly and creatively establishes the healing benefits of Affinity

Web Ad

Part of a full launch campaign, branded web ads helped efficiently announce the new product to the marketplace

Affinity Product Shot

Provides a differentiating look at fresh allograft versus dry or cryopreserved options.

Share This